DK*300 Volumetric Infusion Controller
by Deka Research & Development Corp. 510(k)
Active
510(k) K843254
Overview
The DK*300 Volumetric Infusion Controller is an electronic infusion controller designed for intravascular use. It is classified as a Class II medical device under regulation number 880.5725 and is intended for general hospital settings.
The device received FDA 510(k) clearance (K843254) on October 11, 1984, and is substantially equivalent to a predicate device. It is manufactured by Deka Research & Development Corp. and is supplied as a non-sterile, reusable electronic controller for infusion therapy.
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK843254 | Date11 Oct 1984 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- LDR
- Device Class
- Class II
- Regulation
- 21 CFR Part 880.5725
- Advisory Committee
- General Hospital
- FDA Decision
- SESE Substantially Equivalent
Other devices from Deka Research & Development Corp.
Questions
What is the DK*300 Volumetric Infusion Controller used for?
The DK*300 Volumetric Infusion Controller is an electronic infusion controller designed for intravascular use, intended for general hospital settings to deliver fluids or medications with controlled flow rates during infusion therapy.
Is the DK*300 Volumetric Infusion Controller sterile or non-sterile, and is it single-use or reusable?
The DK*300 Volumetric Infusion Controller is supplied as a non-sterile, reusable electronic controller, meaning it is not provided in a sterile condition and is intended for multiple uses after appropriate cleaning and disinfection between patients.
What regulatory pathway was used for the DK*300 Volumetric Infusion Controller, and when was it cleared?
The DK*300 Volumetric Infusion Controller received FDA 510(k) clearance under submission K843254 on October 11, 1984, and was determined to be substantially equivalent to a predicate device, which is the regulatory route for moderate-risk Class II devices.